Dr Jon Moore
Health Care
Horizon
Austria
Biography
Jon Moore joined Horizon Discovery to manage its portfolio of target validation alliances in 2012 and became CSO in 2014. As Head of Translational Science he leads a broad ranging internal research program that aims to deliver opportunities for spin out companies and also milestoned licensing deals. Initially, this focused on synthetic lethal and immuno-oncology approaches to cancer, but is now widening its scope to encompass cell therapies. Jon is a Director and co-founder of Avvinity Therapeutics, a joint venture between Horizon and Centauri Therapeutics that is exploring the potential of a novel ablative therapy for cancer.
Research Interest
Health Care
